January 12, 2026. Infinitusbio.AI, a U.S.-based Pharmatech company and creator of the proprietary Simulative AI Digital Cell Clone platform, and Oncovita, a Paris-based biotechnology company spun out ...
Scientists at Mount Sinai have created an artificial intelligence system that can predict how likely rare genetic mutations are to actually cause disease. By combining machine learning with millions ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only identifies disease-causing genetic mutations but also predicts the type of ...
Metagene-1, an advanced artificial intelligence (AI) model, is poised to significantly enhance the detection and prevention of biological threats. Developed through a collaboration between Prime ...
Researchers have developed PhyloFrame, a machine-learning tool that uses artificial intelligence to account for ancestral diversity in genetic data. University of Florida researchers are addressing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback